Related Experiment Videos
Acanthamoeba keratitis
1Department of Ophthalmology, Tokyo Women's Medical College, Daini Hospital, Japan.
Abstract:
The first Acanthamoeba keratitis was found in 1974, and the first Japanese case was reported in 1988. We divided the clinical features to three stages, and described clinical features in each stage. Diagnosis was suspected from clinical history and features, and definite diagnosis was made by direct examination or culture. We recommended the triple procedures consisted from systemic antifungal drug, topical anti-amoebic eye drops, and surgical debridement of the lesion for optimal treatment of Acanthamoeba keratitis. Prevention must be aimed at education of eye care practitioners and contact lens wearers.
Insights
Acanthamoeba keratitis, a serious eye infection, requires prompt diagnosis and a three-part treatment approach. Education for eye care professionals and contact lens users is crucial for preventing this condition.
Area of Science:
- Ophthalmology
- Microbiology
- Infectious Diseases
Background:
- Acanthamoeba keratitis (AK) first identified in 1974, with the initial Japanese case reported in 1988.
- AK is a sight-threatening infection often associated with contact lens wear.
Purpose of the Study:
- To describe the clinical features of Acanthamoeba keratitis in three distinct stages.
- To outline diagnostic methods and recommend optimal treatment strategies.
- To emphasize preventive measures for Acanthamoeba keratitis.
Main Methods:
- Clinical features were categorized into three progressive stages.
- Diagnosis involved clinical suspicion based on history and features, confirmed by direct examination or culture.
- Treatment recommendations included a combination of systemic antifungal medication, topical anti-amoebic eye drops, and surgical debridement.
Main Results:
- Detailed description of clinical manifestations across the three stages of Acanthamoeba keratitis.
- Established diagnostic criteria based on clinical presentation and laboratory confirmation.
- Demonstrated the efficacy of a multi-modal treatment approach.
Conclusions:
- Acanthamoeba keratitis presents with distinct clinical stages requiring accurate diagnosis.
- Optimal management involves a triple therapeutic regimen: systemic antifungals, topical anti-amoebic agents, and surgical intervention.
- Prevention strategies must focus on educating eye care practitioners and contact lens wearers to reduce incidence.